Read + Share
Amedeo Smart
Independent Medical Education
Bi WL, Nayak L, Meredith DM, Driver J, et al. Activity of PD-1 blockade with Nivolumab among patients with recurrent atypical/anaplastic meningioma: Phase II trial results. Neuro Oncol 2021 May 20. pii: 6279078. doi: 10.1093.PMID: 34015129
Email
LinkedIn
Facebook
Twitter
Privacy Policy